Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV001031114 | SCV001194420 | pathogenic | Chuvash polycythemia; Von Hippel-Lindau syndrome | 2022-09-26 | criteria provided, single submitter | clinical testing | This variant is a gross deletion of the genomic region encompassing exon(s) 1 of the VHL gene, which includes the initiator codon. This deletion extends beyond the assayed region for this gene and therefore may encompass additional genes. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in VHL are known to be pathogenic (PMID: 8956040, 12202531, 29891534, 31350093). A similar copy number variant has been observed in individual(s) with von Hippel-Lindau syndrome (PMID: 8069305, 10830910, 19764026). For these reasons, this variant has been classified as Pathogenic. |